JNK contributes to the tumorigenic potential of human cholangiocarcinoma cells through the mtor pathway regulated GRP78 induction

10Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Less is known about the roles of c-Jun N-terminal kinase (JNK) in cholangiocarcinoma (CCA). Here, we report that JNK exerts its oncogenic action in human CCA cells, partially due to the mammalian target of rapamycin (mTOR) pathway regulated glucose-regulated protein 78 (GRP78) induction. In human CCA cells, the phosphorylation of eukaryotic initiation factor alpha (eIF2a) results in the accumulation of activating transcription factor 4 (ATF4) and GRP78 independent of unfolded protein response (UPR). Suppression of GRP78 expression decreases the proliferation and invasion of human CCA cells. It's notable that mTOR is required for eIF2a phosphorylation-induced ATF4 and GRP78 expression. Importantly, JNK promotes eIF2a/ATF4-mediated GRP78 induction through regulating the activity of mTOR. Thus, our study implicates JNK/mTOR signaling plays an important role in cholangiocarcinogenesis, partially through promoting the eIF2a/ATF4/GRP78 pathway.©2014 Feng et al.

Cite

CITATION STYLE

APA

Feng, C., He, K., Zhang, C., Su, S., Li, B., Li, Y., … Dai, R. (2014). JNK contributes to the tumorigenic potential of human cholangiocarcinoma cells through the mtor pathway regulated GRP78 induction. PLoS ONE, 9(2). https://doi.org/10.1371/journal.pone.0090388

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free